Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 27,355 | 28,529 | 27,244 | 23,376 | 22,002 |
| Cost of Goods | 5,891 | 5,848 | 5,437 | 5,408 | 5,284 |
| Gross Profit | 21,464 | 22,681 | 21,807 | 17,968 | 16,718 |
| Operating Expenses | 26,776 | 24,940 | 22,916 | 21,423 | 23,057 |
| Operating Income | -4,421 | -1,411 | -672 | -3,047 | -6,055 |
| Other Income | -77 | -118 | 34 | 88 | 318 |
| Pre-tax Income | -4,498 | -1,529 | -638 | -2,959 | -5,737 |
| Income Tax | 96 | 243 | 164 | 242 | 243 |
| Net Income Continuous | -4,594 | -1,772 | -802 | -3,201 | -5,980 |
| Net Income | $-4,594 | $-1,772 | $-802 | $-3,201 | $-5,980 |
| EPS Basic Total Ops | -0.12 | -0.05 | -0.02 | -0.09 | -0.16 |
| EPS Basic Continuous Ops | -0.12 | -0.05 | -0.02 | -0.09 | -0.16 |
| EPS Diluted Total Ops | -0.12 | -0.05 | -0.02 | -0.09 | -0.16 |
| EPS Diluted Continuous Ops | -0.12 | -0.05 | -0.02 | -0.09 | -0.16 |
| EBITDA(a) | $-3,375 | $-471 | $232 | $-1,902 | $-5,096 |